Cited 0 times in
Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:17:24Z | - |
dc.date.available | 2023-06-02T01:17:24Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194795 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | C-H. Chiu | - |
dc.contributor.googleauthor | E. Massarelli | - |
dc.contributor.googleauthor | S.P. Chawla | - |
dc.contributor.googleauthor | G.L. Buchschacher Jr. | - |
dc.contributor.googleauthor | K. Goto | - |
dc.contributor.googleauthor | S-W. Kim | - |
dc.contributor.googleauthor | T.R. Overbeck | - |
dc.contributor.googleauthor | H.H.F. Loong | - |
dc.contributor.googleauthor | C.E. Chee | - |
dc.contributor.googleauthor | P. Garrido | - |
dc.contributor.googleauthor | S. Heinzmann | - |
dc.contributor.googleauthor | B. Pitcher | - |
dc.contributor.googleauthor | T. John | - |
dc.identifier.doi | 10.1016/j.annonc.2022.02.137 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422002538 | - |
dc.citation.volume | 33 | - |
dc.citation.number | suppl 2 | - |
dc.citation.startPage | S82 | - |
dc.citation.endPage | S83 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(suppl 2) : S82-S83, 2022-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.